Brief Report - (2025) Volume 11, Issue 6
Received: 01-Dec-2025, Manuscript No. antimicro-26-183058;
Editor assigned: 03-Dec-2025, Pre QC No. P-183058;
Reviewed: 17-Dec-2025, QC No. Q-183058;
Revised: 22-Dec-2025, Manuscript No. R-183058;
Published:
29-Dec-2025
, DOI: 10.37421/2472-1212.2025.11.433
Citation: Al-Zahrani, Mohammed. ”Combating Antimicrobial Resistance: A Surveillance Imperative.” J Antimicrob Agents 11 (2025):433.
Copyright: © 2025 Al-Zahrani M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Antimicrobial resistance (AMR) surveillance systems are a critical component of global public health strategies, providing essential data for tracking the emergence and spread of resistant pathogens. These systems are indispensable for informing public health policies, guiding clinical treatment strategies, and rigorously evaluating the effectiveness of implemented interventions [1].
Effective surveillance programs are fundamentally reliant on the establishment of robust laboratory infrastructure, the consistent application of standardized methodologies, and the timely dissemination of collected data to relevant stakeholders [1].
However, significant challenges persist, including resource limitations, particularly pronounced in low- and middle-income countries, and the imperative need for integrated surveillance approaches that encompass data from human, animal, and environmental sectors, often referred to as the One Health approach [1].
The integration of advanced genomic surveillance techniques into traditional AMR monitoring frameworks is ushering in a new era, profoundly transforming our capacity to understand complex transmission dynamics and to swiftly identify novel resistance mechanisms as they emerge [2].
The application of whole-genome sequencing (WGS) technology enables high-resolution tracking of infectious disease outbreaks and facilitates the rapid identification of concerning pathogen strains with concerning resistance profiles [2].
This sophisticated genomic approach serves as a powerful complement to conventional phenotypic susceptibility testing, collectively providing a more comprehensive and nuanced understanding of the multifaceted AMR landscape [2].
National action plans represent a vital and foundational element for coordinating and consolidating diverse efforts aimed at effectively combating the growing threat of antimicrobial resistance. These comprehensive plans are typically designed to involve multiple crucial sectors, including healthcare delivery, agricultural practices, and environmental management, thereby fully reflecting the holistic One Health approach to public health [3].
Successful and impactful implementation of these national strategies is heavily contingent upon sustained political will, the allocation of adequate financial resources, and robust intersectoral collaboration among all involved parties [3].
Strengthening laboratory capacity stands as a cornerstone of any effective AMR surveillance system, ensuring the reliability and accuracy of the data generated. This vital effort encompasses ensuring widespread access to appropriate and up-to-date diagnostic tools, cultivating a skilled workforce of trained laboratory personnel, and establishing rigorous, quality-assured external quality assessment programs to maintain high standards [4].
By fortifying and expanding laboratory networks, it becomes significantly easier to achieve standardized data collection and consistent reporting across different geographical regions and healthcare settings [4].
Ensuring the highest standards of data quality and achieving timely reporting are absolutely critical for maximizing the utility and impact of AMR surveillance data in public health decision-making. Inaccurate or unacceptably delayed data can inadvertently lead to misinformed policy decisions and significantly hinder the effectiveness of public health responses to emerging resistance threats [5].
Therefore, substantial investment in developing and maintaining robust data management systems and actively promoting seamless data sharing among all relevant entities are essential steps [5].
The World Health Organization's Global Antimicrobial Resistance and Use Surveillance System (GLASS) stands as a paramount initiative dedicated to establishing standardized global AMR surveillance practices. GLASS endeavors to systematically collect and meticulously analyze comparable data on both antimicrobial resistance patterns and antimicrobial drug usage across a diverse range of countries [6].
This systematic approach is designed to significantly facilitate international collaboration and ultimately lead to more informed and effective decision-making processes at both national and global levels [6].
Fostering interdisciplinary collaboration is not merely beneficial but fundamental to achieving effective and comprehensive AMR surveillance. Bringing together a diverse range of experts from fields such as infectious diseases, microbiology, public health policy, epidemiology, and veterinary medicine is crucial [7].
This synergistic collaboration ensures a truly comprehensive understanding of the complex AMR challenge and significantly facilitates the development and implementation of integrated, multi-pronged strategies to address it [7].
The surveillance of antimicrobial use (AMU) is recognized as being as critically important as the surveillance of antimicrobial resistance (AMR) itself. A thorough understanding of the prevailing patterns of antimicrobial drug consumption in both human and animal health sectors, as well as within agricultural contexts, provides essential context for interpreting observed AMR trends [8].
Furthermore, this understanding is vital for identifying specific areas where targeted interventions can be most effectively implemented to promote judicious antimicrobial stewardship [8].
Leveraging cutting-edge technological advancements, such as the widespread adoption of mobile health (mHealth) applications and sophisticated data analytics platforms, offers a powerful means to significantly enhance both the efficiency and the overall reach of existing AMR surveillance systems. These innovative tools are capable of facilitating real-time data collection directly from the field, improving critical communication channels among stakeholders, and enabling more advanced and insightful data analysis [9].
Effectively addressing the pervasive and growing threat of antimicrobial resistance necessitates sustained and unwavering political commitment, coupled with substantial and consistent investment in essential public health infrastructure. Robust surveillance systems represent a critically important component of this necessary investment, providing the indispensable evidence base required to inform the implementation of effective control measures and ultimately safeguard global health security [10].
Antimicrobial resistance (AMR) surveillance systems are paramount for monitoring the emergence and dissemination of resistant pathogens, providing critical data that underpins public health policies, treatment guidelines, and intervention assessments [1].
The success of these systems hinges on robust laboratory infrastructure, standardized methods, and swift data dissemination [1].
However, resource limitations, especially in lower-income nations, and the need for integrated human-animal-environment data present ongoing challenges [1].
The incorporation of genomic surveillance into traditional AMR monitoring is revolutionizing our understanding of transmission dynamics and the discovery of novel resistance mechanisms. Whole-genome sequencing allows for detailed outbreak tracking and rapid identification of concerning strains, complementing phenotypic testing for a complete AMR picture [2].
National action plans are essential for coordinating AMR combat efforts across multiple sectors, including healthcare, agriculture, and the environment, aligning with the One Health framework. Effective execution depends on political backing, funding, and intersectoral cooperation [3].
Building laboratory capacity is fundamental to reliable AMR surveillance, ensuring access to diagnostics, trained personnel, and quality assurance programs. Enhanced laboratory networks promote standardized data collection and reporting [4].
High-quality and timely AMR surveillance data are crucial for informed decision-making and effective public health responses. Investment in data management systems and data sharing initiatives is therefore essential [5].
The WHO's Global Antimicrobial Resistance and Use Surveillance System (GLASS) is a key initiative for standardizing global AMR surveillance. It aims to gather and analyze comparable data on AMR and antimicrobial use worldwide, fostering international cooperation and evidence-based decisions [6].
Interdisciplinary collaboration, involving experts in infectious diseases, microbiology, public health, epidemiology, and veterinary medicine, is vital for a holistic understanding of AMR and the development of integrated strategies [7].
Surveillance of antimicrobial use (AMU) is as important as AMR surveillance. Understanding AMU patterns in human and animal health, as well as agriculture, provides context for AMR trends and highlights areas for stewardship interventions [8].
Technological innovations, such as mHealth and data analytics platforms, can significantly improve AMR surveillance efficiency and reach. These tools facilitate real-time data collection, communication, and advanced data analysis [9].
Sustained political commitment and investment in public health infrastructure are necessary to tackle AMR. Surveillance systems are a critical investment, providing the evidence base for effective control measures and global health security [10].
Antimicrobial resistance (AMR) surveillance systems are vital for tracking pathogen resistance, informing public health, and guiding treatment strategies. Effective surveillance requires strong laboratory infrastructure, standardized methods, and timely data dissemination, though resource limitations and the need for integrated data remain challenges. Genomic surveillance, utilizing whole-genome sequencing, enhances understanding of transmission and resistance mechanisms. National action plans, encompassing multiple sectors and adopting a One Health approach, are crucial for coordinated efforts, requiring political will and funding. Laboratory capacity building, including access to diagnostics and trained personnel, is fundamental for reliable data. Ensuring data quality and timely reporting is essential for effective decision-making, necessitating investment in data management systems. The WHO's GLASS initiative promotes standardized global surveillance. Interdisciplinary collaboration among diverse experts is key to a comprehensive understanding and strategy development. Surveillance of antimicrobial use provides context for AMR trends and identifies stewardship opportunities. Technological innovations like mHealth and data analytics can improve surveillance efficiency. Ultimately, sustained political commitment and investment in public health infrastructure, including surveillance, are critical for combating AMR and ensuring global health security.
None
None
Journal of Antimicrobial Agents received 444 citations as per Google Scholar report
